<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04682886</url>
  </required_header>
  <id_info>
    <org_study_id>82030047</org_study_id>
    <nct_id>NCT04682886</nct_id>
  </id_info>
  <brief_title>Radiomics Analysis of Focal Liver Lesions Based on Contrast-Enhanced Ultrasound Imaging</brief_title>
  <official_title>Research on Key Techniques for Intelligent Diagnosis and Ablation Decision-making of Liver Cancer and Evolution by Contrast-enhanced Ultrasound</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ping Liang</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese PLA General Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Contrast-enhanced ultrasound (CEUS) substantially improves the potential of ultrasound (US)&#xD;
      for the identification and characterization of focal liver lesions (FLLs). Compared to&#xD;
      contrasted-enhanced MRI and CT, it has some unique advantages, such as the absence of&#xD;
      ionizing radiation, and easy operability and repeatability. However, the efficacy of CEUS in&#xD;
      diagnosing liver lesions is challenged by several factors including being highly dependent on&#xD;
      doctor's experience, low signal-to-noise ratio, and low interobserver agreement. Therefore,&#xD;
      it is a beneficial attempt to construct an intelligent CEUS diagnosis system using digital&#xD;
      information technology. This study aims to collect standard data of CEUS cines recordings and&#xD;
      develop deep learning model for accurate segmentation, detection and classification of liver&#xD;
      lesions.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>AUC value</measure>
    <time_frame>through study completion, an average of 7 year</time_frame>
    <description>Area under the receiver operating characteristic (ROC) curve (AUCï¼‰</description>
  </primary_outcome>
  <primary_outcome>
    <measure>specificity</measure>
    <time_frame>through study completion, an average of 7 year</time_frame>
    <description>diagnosis specificity of intelligent CEUS analysis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>sensitivity</measure>
    <time_frame>through study completion, an average of 3 year</time_frame>
    <description>diagnosis sensitivity of intelligent ultrasound analysis</description>
  </primary_outcome>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Focal Liver Lesions</condition>
  <condition>Contrast-enhanced Ultrasound</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>diagnosis</intervention_name>
    <description>there is no intervention diagnosis or treatment for patients</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients with focal liver lesions&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. patients with a solid liver tumor visible during routine ultrasound and received CEUS.&#xD;
&#xD;
          2. disease history and standard of reference of the lesions can be acquired&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. hypersensitivity for ultrasound contrast media&#xD;
&#xD;
          2. pregnant or lactating patients&#xD;
&#xD;
          3. previously treated lesions or local relapse from previously treated lesions&#xD;
&#xD;
          4. diffuse tumors&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jie Yu, Dr</last_name>
    <phone>15901417963</phone>
    <email>jiemi301@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Chinese PLA General Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100853</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jie Yu, Doctor</last_name>
      <phone>8601066939530</phone>
      <email>jiemi301@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 21, 2020</study_first_submitted>
  <study_first_submitted_qc>December 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 24, 2020</study_first_posted>
  <last_update_submitted>December 21, 2020</last_update_submitted>
  <last_update_submitted_qc>December 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Chinese PLA General Hospital</investigator_affiliation>
    <investigator_full_name>Ping Liang</investigator_full_name>
    <investigator_title>Prof</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

